Sarcoma  >>  peripheral blood stem cell transplantation  >>  Phase 2
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
peripheral blood stem cell transplantation / National Cancer Institute
NCT00003657: High-dose ICE With Amifostine

Completed
2
24
US
filgrastim, Amifostine, Ethyol®, Carboplatin, Paraplatin, Etoposide, Toposar, VePesid, Etopophos, Ifosfamide, Ifex, peripheral blood stem cell transplantation
Dana-Farber Cancer Institute, National Cancer Institute (NCI)
Bladder Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
11/00
06/02
NCT00001566: A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Completed
2
42
US
therapeutic autologous dendritic cells, indinavir sulfate, Crixivan, peripheral blood stem cell transplantation
National Cancer Institute (NCI)
Ewing's Sarcoma, Rhabdomyosarcoma
09/08
09/08
NCT00245011: Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma

Completed
2
11
US
filgrastim, Neupogen, ifosfamide, Ifex, peripheral blood stem cell transplantation, Sm-EDTMP (low dose), sm-EDTMP (higher dose)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)
Sarcoma
10/08
03/09
NCT00043979: Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

Completed
2
60
US
F-18 Fluorodeoxyglucose, FDG, therapeutic allogeneic lymphocytes, cyclophosphamide, Cytoxan, cyclosporine, Sandimmune, doxorubicin hydrochloride, Adriamycin, etoposide, Vepesid, fludarabine phosphate, Fludara, melphalan, Alkeran, prednisone, Deltasone, sirolimus, Rapamune, tacrolimus, Prograf, vincristine sulfate, Oncovin, peripheral blood stem cell transplantation, PBSCT, Filgrastim, Peripheral Blood Stem Cell donation
National Cancer Institute (NCI)
Sarcoma
05/09
12/11
NCT00357396: Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors

Completed
2
10
US
graft versus host disease prophylaxis/therapy, busulfan, melphalan, thiotepa, allogeneic bone marrow transplantation, allogeneic hematopoietic stem cell transplantation, peripheral blood stem cell transplantation
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Sarcoma
10/09
10/09
NCT00002601: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma

Completed
2
13
US
filgrastim, cisplatin, doxorubicin hydrochloride, ifosfamide, melphalan, peripheral blood stem cell transplantation
City of Hope Medical Center, National Cancer Institute (NCI)
Sarcoma
09/14
09/14
NCT00005952: Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Completed
1/2
30
US
filgrastim, temozolomide, peripheral blood stem cell transplantation
Duke University, National Cancer Institute (NCI)
Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Neuroblastoma, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor
11/05
11/05
NCT00006234: Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone

Completed
1/2
US
peripheral blood stem cell transplantation, holmium Ho 166 DOTMP
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Metastatic Cancer, Sarcoma
 
03/06

Download Options